Categories LATEST

Agilent Technologies Q3 2023 Earnings Call: Listen Live and Get the Real-Time Transcript

Medical device company Agilent Technologies, Inc. (NYSE: A) will be reporting financial results today evening, even as the earnings season reaches its very end.

Listen to Agilent’s Q3 2023 earnings call live and read the real-time transcript

When Agilent’s third-quarter 2023 report comes after the closing bell, the market will be looking for adjusted earnings of $1.36 per share, which is higher by two cents than the EPS reported in the prior-year quarter. Meanwhile, revenues are expected to decline 3.4% annually to $1.66 billion in the July quarter.

In the second quarter, the Santa Clara, California-based company’s profit rose to $1.27 per share from $1.13 per share in the year-ago period, on an adjusted basis. Reported net income moved up to $302 million or $1.02 per share from $274 million or $0.91 per share last year. At $1.72 billion, Q2 revenues were up 7% year-over-year.

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

Nike (NKE) looks set to beat hurdles and build a brighter future

Nike, Inc. (NYSE: NKE) has long been ruling the sportswear market but the company had its share of problems when headwinds like the pandemic and economic slowdown hit the business

Electronic Arts (EA): A few points to keep in mind if you have an eye on this gaming company

Shares of Electronic Arts Inc. (NASDAQ: EA) stayed green on Friday. The stock has dropped 7% over the past three months. The video game industry has been facing challenges as

Petros Pharma is focused on establishing mechanisms for Rx-to-OTC switch: CCO Fady Boctor

Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) is a pharma company focused on identifying, developing, and commercializing therapeutics for men's health issues. It operates mainly through the business segments of Prescription Medications

Add Comment
Viewing Highlight